BRIEF-Aveo Pharmaceuticals- Tivo-3 study will continue as planned without modification
October 05, 2017 at 17:36 PM EDT
* Aveo Pharmaceuticals Inc - announces completion of Tivo-3 study futility analysis with no changes to study protocol